Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid in Post-MI Patients Undergoing PCI
NCT05360602Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of alpha-lipoic acid in ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Occurrence of No-Reflow phenomena at 1 week. Started Jan 2022; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05360602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05360602.